Catalent Provides Business Update and Names Ricky Hopson as Interim Chief Financial Officer
Catalent, Inc. today announced a business update.
Uncategorized
Soligenix Provides Regulatory Update on HyBryte™
Soligenix, Inc. announced today that the Company convened a Type A Meeting with the United States (U.S.) Food and Drug Administration.
Soligenix Provides Regulatory Update on HyBryte™ Read More »
Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration
Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA ® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration.
Phase Genomics Collaborates with Element Biosciences to Optimize Cytogenomics for Liquid and Solid Tumor Samples
Phase Genomics, Inc and Element Biosciences , the developer of an innovative DNA sequencing platform disrupting genomics, today released new details of their first collaboration leveraging Phase Genomics’ proprietary OncoTerra™ cytogenomics platform and the Element AVITI System for next generation sequencing (NGS).
Lo que revelan los esqueletos fósiles más antiguos de murciélagos
Hay más de 1.460 especies vivas de murciélagos en el mundo. Estos mamíferos voladores se encuentran en casi todas partes del mundo, con la excepción de las regiones polares y algunas islas remotas. El origen de los murciélagos está envuelto en el misterio. L …
Lo que revelan los esqueletos fósiles más antiguos de murciélagos Read More »
Robots con neuronas vivientes
Discurriendo por la resbaladiza frontera entre los robots enriquecidos con material biológico y los cíborgs, la labor de diversos equipos de científicos en el mundo avanza más rápidamente de lo que lo hacen los juicios morales y la legislación. El e …
¿Por qué nos desperezamos?
En este Short examinamos el curioso acto de desperezarse y sus posibles orígenes y efectos. …
Caris Life Sciences to Showcase Research Highlighting the Clinical Value of Comprehensive Molecular Profiling at the American Association for Cancer Research Annual Meeting
Caris Life Sciences® announced that the company and partners within the Caris Precision Oncology Alliance™ will collectively present four studies across 14 tumor types at the 2023 American Association for Cancer Research Annual Meeting being held April 14-19, 2023 in Orlando, Florida, at Booth Number 130.
Immunis Appoints Neil Sahota as Chief Artificial Intelligence Officer
Immunis, Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, has appointed Neil Sahota as its Chief Artificial Intelligence Officer.
Immunis Appoints Neil Sahota as Chief Artificial Intelligence Officer Read More »
Bio-Thera Solutions Announces BAT1006 Poster Presentations at the 2023 AACR Annual Meeting
Bio-Thera Solutions, Ltd. announced the company will present one poster concerning Phase 1 clinical results for BAT1006 at the 2023 American Association for Cancer Research Annual Meeting taking place April 14 – April 19, 2023 in Orlando, Florida.